Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

The document is a detailed medical reference on skin and genetic disorders.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

cGVHD often severely affects the skin, causing rapid aging and other issues.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

MSC-derived exosomes may help in skin repair and regeneration.

Childhood cancer survivors need better skin care and sun protection.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Allogenic ASCs and ECM transplants are safe and effective for tissue regeneration.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Stem-cell therapy shows promise for skin conditions but needs more research.